Condition
Preeclampsia (PE) clinical trials and research
As of November 12, 2026, Find a Trial lists 14 Preeclampsia (PE) clinical trials that are recruiting, at sites in 10 countries (most in United States (4), Spain (2), Turkey (Türkiye) (1)). 1 was first registered in the last 30 days. By phase: Phase 2 (2). The most active sponsors are Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (2), University of Tennessee Graduate School of Medicine (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 14Clinical trials
- 1New in 30 days
- 10Countries
Newest Preeclampsia (PE) clinical trials
All recruiting trials (14)
-
Preeclampsia and normal pregnancy: retinal microcirculation using OCTA
This study tests retinal blood flow in pregnant people with preeclampsia compared to healthy pregnant people using OCTA imaging.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Origins, features, and effects of preeclampsia on mother and baby
This project will follow pregnant women diagnosed with preeclampsia through late pregnancy, delivery, and early postpartum to collect clinical data and biological samples to see how preeclampsia affects mothers and their babies.
-
National first-trimester screening program to prevent preeclampsia in Denmark
This program will try a new first-trimester screening for pregnant women with a single pregnancy in Denmark to find those at high risk of preeclampsia and offer early prevention such as low-dose aspirin.
-
Blood protein markers and heart changes in pregnant women with preeclampsia
This study tests whether blood proteins can reveal early heart changes in pregnant women with preeclampsia and uses heart ultrasound to see how the heart changes during pregnancy.
-
Heart risk check for young women 3–6 years after pregnancy with or without placental complications.
This project will test an app-based algorithm to see if it can identify cardiovascular risk in women 3–6 years after giving birth, including those who had preeclampsia or low-birth-weight infants.
-
Pravastatin for severe early-onset placental insufficiency
This trial will test whether pravastatin can safely prolong pregnancy and lower risks for pregnant people with severe early-onset preeclampsia or early-onset IUGR between 24+0 and 29+6 weeks.
-
Combined first-trimester screening for pregnancy complications
This project tests a standardized first-trimester screening to see if it can identify pregnant women at 11–13 weeks who are at higher risk for preeclampsia, fetal growth restriction, chromosomal problems, and other serious complications.
-
Using hyperspectral imaging to assess endothelial dysfunction in preeclampsia
This study is testing if a special imaging technique can help doctors see how blood vessel function changes in pregnant women with preeclampsia to better understand the risks for both mom and baby.
-
Examining how aspirin metabolism relates to metabolic dysfunction in pregnant individuals at risk of preeclampsia
This study is trying to see how the way pregnant people process aspirin relates to their metabolic health and the health of their babies, especially for those at risk of preeclampsia.
-
Effects of magnesium sulphate regimens in severe preeclampsia
This study looks at how different treatments with magnesium sulphate can help prevent seizures in pregnant women with severe preeclampsia.
-
Non-invasive screening for preeclampsia in pregnant women
This study is testing a new blood test to see if it can help detect preeclampsia early in pregnant women.
-
Screening for preeclampsia in early pregnancy
This study is testing a new way to screen pregnant women in their first trimester for preeclampsia to see if it can help identify those at risk and improve their health with early treatment.
-
Using progesterone to improve outcomes for mothers and babies with preeclampsia
This study is testing if a hormone treatment can help improve health outcomes for mothers and their babies who have preeclampsia before 34 weeks of pregnancy.
Related topics
Quick answers
How many Preeclampsia (PE) clinical trials are recruiting right now?
14, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (4 trials), Spain (2 trials), Turkey (Türkiye) (1 trial), Egypt (1 trial), Czechia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.